Spanish pharmaceutical company Ferrer and Swiss clinical stage biotechnology company Asceneuron have announced the signing of a licensing agreement in which Ferrer obtains the exclusive worldwide rights to develop and commercialize ASN90 in progressive supranuclear
Tags :Anne-Laure Laplace
Gyrus Capital has acquired healthcare services business Consulcesi Group alongside its founders and management. The company is leading provider of Continuous Medical Education (CME), digital marketing, data analytics and legal services to the healthcare industry.
beqom, a company sponsored inter alia by Goldman Sachs and Eurazeo, receives a USD300 million investment by Sumeru Equity Partners and co-investors. Majority of the investment will fuel additional growth in product innovation to better
Essential Pharma, a portfolio company of Gyrus Capital, has acquired on December 8, 2021, the worldwide rights – except for the USA and India – to iopidine for the adjunctive treatment of glaucoma, and methergine for treating post-partum hemorrhage
